Botanical species · safety record
Phaseolus lunatus
The EFSA Compendium of Botanicals holds 24 constituent measurements and 3 adverse-effect records for Phaseolus lunatus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Phaseolus lunatus L.
Regulatory presence
No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.
What the records describe
Constituents measured
- Cyanogenic glycosides6
- Daidzein2
- Formononetin2
- Genistein2
- Linamarin2
- Lotaustralin2
- Phytic acid2
- Secoisolarisiresinol2
- Biochanin-a1
- Coumestrol1
Plant parts
- Seed23
- Leaves4
Preparations
- Solvent extraction24
Effect types
- Digestive2
- Not reported1
Target tissues
- Digestive1
- Stomach1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Cyanogenic glycosides | Leaves | Solvent extraction | ≥ 0.8 Microgram/gram | Unspecified | Resolve DOI |
| Cyanogenic glycosides | Leaves | Solvent extraction | ≥ 3.3 Microgram/gram | Unspecified | Resolve DOI |
| Cyanogenic glycosides | Leaves | Solvent extraction | ≤ 10.4 Microgram/gram | Unspecified | Resolve DOI |
| Cyanogenic glycosides | Leaves | Solvent extraction | ≤ 8.9 Microgram/gram | Unspecified | Resolve DOI |
| Cyanogenic glycosides | Seed | Solvent extraction | ≥ 0.6 Microgram/gram | Unspecified | Resolve DOI |
| Cyanogenic glycosides | Seed | Solvent extraction | ≤ 1 Microgram/gram | Unspecified | Resolve DOI |
| Hydrocyanic acid | Seed | Solvent extraction | 32 Milligram/kilogram | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
| Linamarin | Seed | Solvent extraction | ≥ 14 Milligram/gram | Chromatographic tests | Resolve DOI |
| Linamarin | Seed | Solvent extraction | ≤ 26 Milligram/gram | Chromatographic tests | Resolve DOI |
| Lotaustralin | Seed | Solvent extraction | ≥ 220 Microgram/gram | Chromatographic tests | Resolve DOI |
| Lotaustralin | Seed | Solvent extraction | ≤ 790 Microgram/gram | Chromatographic tests | Resolve DOI |
| Phytic acid | Seed | Solvent extraction | ≤ 11.6 Microgram/gram | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
| Phytic acid | Seed | Solvent extraction | ≥ 8 Microgram/gram | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
| Biochanin-a | Seed | Solvent extraction | ≤ 2.7 Microgram/100 gram | GC-MS | No resolvable identifier |
| Coumestrol | Seed | Solvent extraction | ≤ 10 Microgram/100 gram | GC-MS | No resolvable identifier |
| Daidzein | Seed | Solvent extraction | ≥ 12.2 Microgram/100 gram | GC-MS | No resolvable identifier |
| Daidzein | Seed | Solvent extraction | ≤ 89 Microgram/100 gram | GC-MS | No resolvable identifier |
| Formononetin | Seed | Solvent extraction | ≤ 12.4 Microgram/100 gram | GC-MS | No resolvable identifier |
| Formononetin | Seed | Solvent extraction | ≥ 9 Microgram/100 gram | GC-MS | No resolvable identifier |
| Genistein | Seed | Solvent extraction | ≥ 10.6 Microgram/100 gram | GC-MS | No resolvable identifier |
| Genistein | Seed | Solvent extraction | ≤ 19.2 Microgram/100 gram | GC-MS | No resolvable identifier |
| Matairesinol | Seed | Solvent extraction | — | GC-MS | No resolvable identifier |
| Secoisolarisiresinol | Seed | Solvent extraction | ≥ 158 Microgram/100 gram | GC-MS | No resolvable identifier |
| Secoisolarisiresinol | Seed | Solvent extraction | ≤ 185 Microgram/100 gram | GC-MS | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Digestive | Stomach | Seed | — | Rat (as animal) | Subchronic | Resolve DOI |
| Digestive | Digestive | Seed | — | Human (as organism) | Case report | No resolvable identifier |
| Not reported | — | Seed | — | Human (as organism) | Case report | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Mazur, Witold M., Duke, James A., Wahala, Kristiina., Rasku, Sirpa., Adlercreutz, Herman. Isoflavonoids and lignans in legumes: nutritional and health aspects in humans. Journal of nutritional biochemistry, 1998, vol. 9, no. 4, p. 193-200.
- Guignard, L. The hydrogen cyanide supplying bean (Phaseolus Lunatus). Historical, botanical and chemical study. New procedure for the proof of hydrocyanic acid. machine translation . Bull. des sciences pharmacol., 1906, vol. 13, p. 129-38.
- Betancur-Ancona, D., Segura-Campos, M., Rosado-Rubio, G., Franco, L.S., Chel-Guerrero, L. Chemical composition and anti-nutritional factors in five tropical legume seeds. Beans: nutrition, consumption and health, 2012, p. 117-141.
- Jaff�, W.G. Toxische und Wachstumshemmende Faktoren in Bohnen. Qualitas plantarum et materiae vegetabiles, 1969, vol. 17, no. 2, p. 113-130. DOI
- Laurena, Antonio C., Revilleza, Ma. Jamela R., Mendona, Evelyn Mae T. Polyphenols, Phytate, Cyanogenic Glycosides, and Trypsin Inhibitor Activity of Several Philippine Indigenous Food Legumes. Journal of Food Composition and Analysis, 1994, vol. 7, no. 3, p. 194-202. DOI
- Shlichta, J. Gwen., Glauser, Gaetan., Benrey, Betty. Variation in Cyanogenic Glycosides Across Populations of Wild Lima Beans (Phaseolus lunatus) Has No Apparent Effect on Bruchid Beetle Performance . Journal of chemical ecology, 2014, vol. 40, no. 5, p. 468-475. DOI
- Cressey, P., Saunders, D., Goodman, J. Cyanogenic glycosides in plant-based foods available in New Zealand. Food additives and contaminants - part a chemistry, analysis, control, exposure and risk assessment, 2013, vol. 30, no. 11, p. 1946-1953. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.